THIS COMPANY IS ENGAGED WITH PHARMACETUTICAL BUSINESS.MAINLY PRODUCES INFLAMATORY,BACTIREAL,BIOTICAND PROTEIN MEDICINES
FINANCIAL STATYS OF COMPANY
2008 2009 2010
PROFITS 2.75 CR 3.37 CR 4.67 CR
EPS 7.97 9.65 13.06
BV 63.45 71.48 82.78
DIVIDENT 100% 120% 150%
CURRENT MARKET CAP OF THE COMPANY COMES AROUND 38.4 CR.AT CURRENT VALUATION COMPANY IS TRADING 1.25 *BV,
I STRONGLY BELIEVE THE COMPANY WILL PERFORM WELL IN COMING QTRS AND , COMPANY ANNOUNCES RIGHT ISSUE 1:2 MEDIUM TERM PRESPECTIVE CLIENTS CAN BUY THIS SHARE@100 RANGE ,STOCK IS ATTRACTIVE VALUATION@CMP CAN HOLD FOR THE TGT OF 135-140 IN 2-3MONTHS
No comments:
Post a Comment